This is HOPE®
Breast Cancer is highly curable and it can be successfully treated if detected at an early stage. It can be even avoided through effective breast health education, awareness and prevention.
“Know My Normal” is the key component of the breast health awareness which is crucial to breast cancer risk prediction and early detection.
This is the heart of HOPE®, the first smart breast health digital clinic on Smartphone, which is available since October 2025 for all women over 25 and their primary healthcare providers.
This is HOPE METRIX®
HOPE METRIX® is a cutting-edge GEN-IV AI-assisted rare events screening platform designed by HOPE VALLEY AI to help clinical researchers, HealthTech companies and industry partners gain a better understanding of the incubation of rare events, and early detect their silent weak signals, years before they occur.
Powered by our integrated GEN-IV AI-based technology, HOPE METRIX® integrates complex data, multimodal imaging and multi-physics signals, to (1) ensure multi-year risk modeling, assessment, prediction and simulation, (2) characterize novel predictive risk markers and breakthrough biomarkers, and (3) early detect weak signals of rare events’ incubation, long before symptoms appear.
